Company

KERYX BIOPHARMACEUTICALS INC (0001114220)

Standardized SEC financial data for KERYX BIOPHARMACEUTICALS INC — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001114220 · Pharmaceutical Preparations.

Gross margin

-18.2%

Operating margin

-347.3%

Net margin

-511.0%

Revenue growth (YoY)

215.4%

Return on equity

1000.0%

Free cash flow

-$94.7M

Current ratio

3.12×

EPS (diluted)

$-0.42

Ratios for fiscal year 2016, standardized from SEC filings.

Income statement

USD	FY2016	FY2017
Revenue	$32.0M	—
Cost of revenue	$37.8M	—
Gross profit	-$5.8M	—
Interest expense	$34.2M	$63.0M
Net income	-$161.1M	-$163.4M

Standardized from KERYX BIOPHARMACEUTICALS INC's SEC filings — per-share figures split-adjusted. Full history via the API.

Balance sheet

USD	FY2016	FY2017
Cash & equivalents	$111.8M	$93.5M
Inventory	$12.7M	$28.7M
Total current assets	$132.9M	$141.6M
Property, plant & equipment	$4.2M	$4.5M
Goodwill	$3.2M	$3.2M
Total assets	$141.4M	$158.9M
Total current liabilities

Cash flow

USD	FY2016	FY2017
Operating cash flow	-$86.6M	-$93.5M
Capital expenditures	$2.1M	$1.3M
Free cash flow	-$88.7M	-$94.7M
Investing cash flow	-$2.1M	-$1.3M
Financing cash flow	$198K	$76.5M
Dividends paid	$0	$0

Get 0001114220 data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001114220/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001114220/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View 0001114220 filings on SEC EDGAR →